Omada Health (OMDA) CEO logs 17,258-share exercise-and-sale under 10b5-1 plan
Rhea-AI Filing Summary
Omada Health, Inc.’s Chief Executive Officer Sean P. Duffy reported an amended insider transaction showing a series of same-day option exercises and open-market sales of common stock. Over June 24–26, 2026, he exercised options for 17,258 shares and sold 17,258 shares at prices around the high‑$19 to $20.90 range in pre-planned trades under a Rule 10b5-1 trading plan.
The amendment corrects the original Form 4 by adding the omitted exercise entries and adjusting the number of securities beneficially owned after the transactions. Following these sales, Duffy directly held 411,861 shares of Omada Health common stock, while family trusts held 851,659 additional shares for the benefit of his family members, for which he disclaims beneficial ownership except for his pecuniary interest.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 9,844 | $0.00 | -- |
| Exercise | Stock Option (Right to Buy) | 4,314 | $0.00 | -- |
| Exercise | Common Stock | 9,844 | $5.82 | $57K |
| Sale | Common Stock | 9,844 | $19.6072 | $193K |
| Exercise | Common Stock | 4,314 | $8.28 | $36K |
| Sale | Common Stock | 4,314 | $20.90 | $90K |
| Exercise | Stock Option (Right to Buy) | 300 | $0.00 | -- |
| Exercise | Common Stock | 300 | $5.82 | $2K |
| Sale | Common Stock | 300 | $19.0033 | $6K |
| Exercise | Stock Option (Right to Buy) | 2,800 | $0.00 | -- |
| Exercise | Common Stock | 2,800 | $5.82 | $16K |
| Sale | Common Stock | 2,800 | $19.0139 | $53K |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- This Form 4/A restates in its entirety the original Form 4 filed on 6/26/2026 to report exercise transactions that were inadvertently omitted from the original filing. The exercises reported herein were part of same-day exercise-and-sale transactions, and the corresponding sales were timely reported in the original Form 4. Due to the omission of these exercise transactions, the amount of securities beneficially owned following the sales was understated. The amount of securities beneficially owned has been adjusted in Box 5 of Table I of this Form 4/A to correct the aforementioned error. Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026. This transaction was executed in multiple trades at prices ranging from $19.00 to $19.03. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $19.00 to $19.01. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Held in family trusts for the benefit of the Reporting Person's family members. The Reporting Person disclaims beneficial ownership of the shares held by the family trusts except to the extent of his pecuniary interest therein. 100% of the shares subject to the option are fully vested and exercisable